Horwats’ vision is to build a dual-driven platform for anti-aging and metabolic health. We continuously advance NAD+, MK-7, and GLP-1 research while strengthening global collaborations, compliance support, and supply chain resilience. Our goal is not only to deliver premium raw materials but also to be a long-term partner for clients’ growth. Strategic customers can trust that our planning looks beyond today, focusing on the next five to ten years of industry development. 📩 Contact: sales@horwats.com | WhatsApp: +86 19052754932 #Horwats #FutureVision #AntiAging #MetabolicHealth #Biotech

Injection-grade NAD+ with ≥99% purity is not only a mark of quality but also the foundation of experimental reproducibility. For researchers, batch variability is one of the most uncontrollable factors in studies. Horwats applies advanced purification and strict endotoxin control to guarantee consistency across all batches. We understand that scientists need not just one-time results, but data that can be validated over time. Choosing Horwats means choosing stability and scientific trust. 📩 Contact: sales@horwats.com | WhatsApp: +86 19052754932 #Horwats #NADplus #InjectionGrade #ResearchStability #Biotech

Why is oral NAD+ supplementation limited? Its large molecules are easily degraded in the digestive system and poorly absorbed into the bloodstream, resulting in minimal cellular benefits. That’s why injection-grade NAD+ is the smarter choice. By bypassing the digestive tract, it delivers NAD+ directly into the cells, ensuring higher bioavailability, faster onset, and more reliable results for energy metabolism, DNA repair, and anti-aging interventions. Horwats Biotech provides ultra-pure, injection-grade NAD+ with ≥99% purity, strict endotoxin control, and batch-to-batch consistency. Available in multiple specifications, our NAD+ is trusted by clinics, research institutions, and high-end wellness brands worldwide. 📩 Contact us today to request samples and technical whitepapers: Email: sales@horwats.com | WhatsApp: +86 19052754932 #Horwats #NADplus #InjectionGrade #AntiAging #Biotech #Longevity

Third-Party Test Report: Horwats NAD+ vs 3 Competitors in Blind Test We commissioned an authoritative international third-party lab to conduct blind tests on Horwats NAD+ and three anonymous competitors. Results show Horwats leads comprehensively in key metrics: purity (99.2%), residual solvents (ND), and endotoxin (<0.2EU/mg). Data doesn't lie. We prove quality with facts. sales@horwats.com +86 19052754932(whatsapp) #Horwats #ThirdPartyTest #QualityComparison #DataTransparency

Wall Street Analyst Report: Why Continuous Investment in NAD+ Sector? Goldman Sachs' latest report cites key investment drivers: ①Market CAGR >25% ②End-product gross margins >80% ③Expansion from supplements to pharmaceuticals. Capital, Horwats helps you capture this investment trend. sales@horwats.com +86 19052754932(whatsapp) #Horwats #NADInvestment #MarketTrends #CapitalAnalysis

North American Premium Clinic NAD+ IV Therapy Pricing & Market Analysis NAD+ IV therapy in premium North American clinics typically costs $500-$1000 per session, with full courses exceeding $10000. This reveals significant profit margins and consumer willingness to pay. Horwats provides injectable-grade NAD+ (endotoxin<0.2EU/mg) to help you enter this high-end market. sales@horwats.com +86 19052754932(whatsapp) #Horwats #NADTherapy #PremiumMarket #BusinessModel

Horwats NAD+ CoA Report Explained: What Each Parameter Really Means Can you truly understand CoA reports? Horwats experts decode key parameters for injectable-grade NAD+ CoA: • 【Purity】≥99%: Main content, directly affects efficacy • 【Endotoxin】<0.2EU/mg: Core safety indicator for injection • 【Related substances】<0.5%: Fewer unknowns = safer • 【Bioactivity】≥98%: Ensures product actually works We promise: All data is authentic and traceable. Verification welcome.sales@horwats.com +86 19052754932(whatsapp) #Horwats #CoAExplanation #NAD #QualityTransparencysales

Global Anti-Aging Summit Hot Topic: Latest Clinical Research Progress on NAD+ Good news from recent Global Anti-Aging Summit: Positive Phase II clinical results for NAD+ precursors in sarcopenia and cognitive decline! Data shows: 1000mg daily NAD+ precursor supplementation improved elderly muscle strength by 18% and cognitive test scores by 23% after 12 weeks. Horwats injectable-grade NAD+ supports clinical research.sales@horwats.com +86 19052754932(whatsapp) #Horwats #AntiAgingSummit #NAD #ClinicalResearch

From longevity clinics in Los Angeles to premium recovery centers in Tokyo, NAD+ therapy is sparking a global health wave. 🌍 Our data map shows: North America leads in anti-aging applications, the Asian market is growing the fastest, and Europe focuses on clinical research for neurological repair. Howa's injectable-grade NAD+ already serves clients in 20+ countries and regions worldwide. #GlobalMarket #DataViz #NAD #HealthTrends#Horwats

Case Study: How a Premium IV Clinic Doubled Client Retention Rate with Howa NAD+ Client retention is the lifeline of an IV clinic. Our collaboration with a high-end clinic showed that after switching to Howa's injectable-grade NAD+ (purity ≥99%, endotoxin <0.2 EU/mg), their client retention rate doubled within 6 months. The key reason: higher purity and safety delivered a more significant energy boost and cognitive improvement experience, greatly increasing clients' willingness to repurchase. Choosing reliable raw materials means choosing stable business returns.sales@horwats.com +86 19052754932(whatsapp) #SuccessStory #NADTherapy #RetentionRate #IVClinic #Horwats

Demystifying Enzymatic Synthesis: Why It's the Gold Standard for Injectable-Grade NAD+? The NAD+ therapy market is booming, but the choice of manufacturing process directly dictates the upper limit of product safety and efficacy. ⚗️ Chemical synthesis involves complex pathways, easily introducing unknown impurities and organic solvent residues, posing potential risks for IV injection. In contrast, Enzymatic Biocatalysis, adopted by Howa Biotech, mimics the natural in-vivo synthesis pathway and offers unparalleled advantages: ✅ Ultra-High Purity: Achieves ≥99% main purity effortlessly with a clear and controllable impurity profile. ✅ Extremely Low Endotoxin: Consistently controlled at <0.2 EU/mg, far exceeding injectable-grade standards. ✅ High Bioactivity: Correct spatial structure ensures biological function. For pharmaceutical companies and high-end clinics, choosing a raw material supplier is choosing a risk-control partner. Advanced technology is the first line of defense for safety. sales@horwats.com +86 19052754932(whatsapp) #NAD #IVTherapy #Biotechnology #cGMP #EnzymaticSynthesis

Not all K2 is MK-7. Not all MK-7 is created equal. 💎 The secret to superior bone and cardiovascular health? Bioavailability. Our fermentation-derived All-Trans MK-7 boasts the pristine crystalline structure your formulations deserve. It's the only form your body can truly utilize effectively. ✨ Demand purity. Demand proven performance. 🔬 Harwast Biotech: Premium Ingredients, Powered by Synthetic Biology. sales@horwats.com +86 19052754932(whatsapp) #VitaminK2 #MenaQ7 #AllTrans #BoneHealth #CardiovascularHealth #Nutraceuticals #Bioavailability #HarwastBio